facial paralysis

Trials

Clinical effectiveness study of treating postpartum idiopathic facial paralysis by tonifying qi and blood with acupuncture and moxibustion: a randomized, controlled clinical trial

Not yet recruiting

ITMCTR2200005583

Efficacy evaluation of mirabilite application at Yifeng in the treatment of Bell's palsy in acute stage

Not yet recruiting

NCT07127016

Mindfulness in Nonflaccid Facial Paralysis

24 participants · First posted Aug 17, 2025

Drugs

View all 39 →

Small Molecule

Investigational

Col-118

Small Molecule

Approved

Brimonidine(Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza)

Manufacturer: Allergan inc, Allergan +7 more

Conditions: Increased Intra Ocular Pressure (IOP), Ocular Hypertension +1 more

C₁₁H₁₀BrN₅ · Rx

Small Molecule

Approved

Oxymetazoline(Afrin, Dristan 12-hour Nasal Spray, Kovanaze, Nostrilla, Rhofade, Sinex Long-acting, Upneeq, Zicam Sinus Relief)

Manufacturer: Schering plough healthcare products inc, Johnson and johnson group consumer companies

Conditions: Acquired Blepharoptosis, Allergic Rhinitis (AR) +6 more

C₁₆H₂₄N₂O

Organizations

View all 45 →

Facial Concepts, Inc.

United States

MASSACHUSETTS EYE AND EAR INFIRMARY & PHYSICIAN STAFF, INC.

United States

Revance Therapeutics

United States

News

View all 1156 →

2 months ago

Parotid Gland Cancer in Young Adults: A Case Study of Diagnosis, Treatment, and Recovery

21 hours ago

FDA Grants Breakthrough Therapy Designation to Bevonescein for Real-Time Nerve Visualization in Head and Neck Surgery

last year

Trials

Clinical effectiveness study of treating postpartum idiopathic facial paralysis by tonifying qi and blood with acupuncture and moxibustion: a randomized, controlled clinical trial

Efficacy evaluation of mirabilite application at Yifeng in the treatment of Bell's palsy in acute stage

Mindfulness in Nonflaccid Facial Paralysis

Drugs

Col-118

Brimonidine(Alphagan, Combigan, Lumify, Mirvaso, Onreltea, Qoliana, Simbrinza)

Oxymetazoline(Afrin, Dristan 12-hour Nasal Spray, Kovanaze, Nostrilla, Rhofade, Sinex Long-acting, Upneeq, Zicam Sinus Relief)

Organizations

Facial Concepts, Inc.

MASSACHUSETTS EYE AND EAR INFIRMARY & PHYSICIAN STAFF, INC.

Revance Therapeutics

News

Parotid Gland Cancer in Young Adults: A Case Study of Diagnosis, Treatment, and Recovery

FDA Grants Breakthrough Therapy Designation to Bevonescein for Real-Time Nerve Visualization in Head and Neck Surgery

AI-Powered Facial Analysis Technology Enters Clinical Trials for Depression Screening